Syngene

#CRDMO #Syngene

Syngene appoints Mittal as Managing Director and CEO 

CRDMO Syngene International has appointed Siddharth Mittal as Managing Director and Chief Executive Officer.  Mittal succeeds Peter Bains, who completed his tenure as Managing Director & CEO on 30 June 2026.   Mittal joins Syngene from Biocon Limited, where he most recently served as the Managing Director and Chief Executive Officer. Read More

#News

#CRDMO #Syngene

Syngene announces leadership appointments to drive growth

Syngene International has announced the appointment of Abhijit Zutshi as Chief Commercial Officer (CCO) and Maninder Kapoor Puri as Chief Human Resources Officer (CHRO).  As a member of the Executive Committee, Zutshi is set to lead Syngene’s commercial activities and is tasked with further expanding the CRDMO’s pipeline… Read More

#News

#Drug discovery #John Hopkins University #Syngene

Syngene and John Hopkins University to advance drug discovery  

Syngene International has announced a strategic collaboration with John Hopkins University to advance early-stage drug discovery programmes.  The collaboration will incorporate Syngene’s SynVent, a fully integrated drug discovery and development platform that spans discovery biology, medicinal and synthetic chemistry, DMPK (Drug Metabolism and Pharmacokinetics), toxicology, and early development.   Syngene also intends to use its… Read More

#Business & Investment #News